Caris Life Sciences,�Inc. (CAI)
(Delayed Data from NSDQ)
$28.95 USD
-1.35 (-4.46%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $28.97 +0.02 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Caris Life Sciences,?Inc. has a market cap of $7.71B, which represents its share price of $30.30 multiplied by its outstanding shares number of 254.40M. As a mid-cap company, CAI's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CAI 28.95 -1.35(-4.46%)
Will CAI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAI based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAI
Caris Life Sciences Publishes Study Showing AI Signature-positive Breast Cancer Patients Live ...
Caris Life Sciences publishes new study on AI-based image analysis model
Caris Life Sciences Inc (CAI) Unveils Breakthrough AI Tool for Cancer Diagnosis | CAI stock news
Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin ...
ClearBridge Select Strategy Q2 2025 Commentary